Danaher

Evolution in Point of Care Clinical Chemistry Test Kits to Drive Global Market Revenue

New Delhi, September 14, 2019: Point of care testing volume has evolved and increased over the years. The growth is…

5 years ago

Cepheid unveils latest TB-testing system; announces plans to establish a manufacturing footprint for Xpert® MTB/RIF tests in India

New Delhi, July 15, 2018: US-based leading molecular diagnostics company, Cepheid Inc. (a wholly owned subsidiary of Danaher, a NYSE-listed…

6 years ago